LivaNova PLC

NASDAQ:LIVN  
77.65
+0.95 (+1.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.81B
Current PEN/A
Forward PE 63.13
2yr Forward PE 37.88
See more stats
Estimates Current Quarter
Revenue$268.99 Million
Adjusted EPS$0.66
See more estimates
10-Day MA$74.17
50-Day MA$68.19
200-Day MA$55.02
See more pivots

LivaNova Plc Stock, NASDAQ:LIVN

20 Eastbourne Terrace, 20 Eastbourne Terrace, London, Greater London W2 6LG
United Kingdom
Phone: +44.203.325.0660
Number of Employees: 4000

Description

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.